Lamotrigine Tablet
Product Images NDC 65862-228

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 65862-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Lamotrigine Fig1)

A Kaplan-Meier failure probability curve showing data over approximately 100 weeks. Two lines represent groups receiving Lamotrigine and placebo, respectively, with marked censored data points. The y-axis indicates failure probability percentage, and the x-axis shows time in weeks.*

FDA Label Image

Package Label-principal Display Panel (200 mg (100 Tablet Bottle))

Label for Lamotrigine Tablets USP 200 mg, a tablet form drug for further processing by Aurobindo Pharma Limited. The label indicates 100 tablets per container and includes storage instructions, distributor information for Aurobindo Pharma USA, Inc., and an NDC code 65862-230-01. It advises pharmacists to dispense an accompanying medication guide and shows a barcode on the right side.*

FDA Label Image

Package Label-principal Display Panel (200 mg Blister Carton (10 x 10 Unit-dose))

Packaging label for Lamotrigine Tablets USP 200 mg by Aurobindo Pharma Limited. The label shows a white and teal carton design with the product name and strength prominently displayed in pink and black text. The package contains 100 tablets in unit-dose format. Additional text includes pharmacist dispensing instructions and manufacturer details.*

FDA Label Image

Figure 2 (Lamotrigine Fig2)

A Kaplan-Meier failure probability curve showing failure probability (%) on the y-axis and weeks on the x-axis for lamotrigine compared to placebo. The graph includes censored data points and indicates failure probability over an 80-week period with lamotrigine and placebo as separate lines.*

FDA Label Image

Figure 3 (Lamotrigine Fig3)

Illustration of Lamotrigine tablets in four strengths: 25 mg, 100 mg, 150 mg, and 200 mg. Each tablet has a distinct color and debossed letter/number combinations: 25 mg white to off-white with 'D' and '93'; 100 mg peach with 'D' and '94'; 150 mg cream with 'D' and '95'; 200 mg blue with 'D' and '96'. All tablets have a scoreline on the opposite side from the debossing.*

FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablet Bottle))

Lamotrigine Tablets USP 25 mg label from Aurobindo Pharma Limited, indicating the product contains 100 scored tablets. The label includes storage instructions (20° to 25°C, with exceptions) and a note that each tablet contains 25 mg of lamotrigine. The product is distributed by Aurobindo Pharma USA, Inc., with manufacturing stated as Made in India. A barcode is present on the right side of the label.*

FDA Label Image

Package Label-principal Display Panel (25 mg Blister Carton (10 x 10 Unit-dose))

Lamotrigine Tablets USP 25 mg unit-dose carton from Aurobindo Pharma Limited featuring dosage strength prominently in green. The package indicates 100 tablets total (10 x 10 unit-dose) with directions to dispense accompanying Medication Guide. The label includes a barcode, NDC number 65862-227-78, and storage instructions. The design includes teal and blue curved graphics on a white background.*

FDA Label Image

Package Label-principal Display Panel (100 mg (100 Tablet Bottle))

Label for Lamotrigine Tablets USP 100 mg by Aurobindo Pharma USA, Inc. The label states each scored tablet contains 100 mg Lamotrigine USP, with a package count of 100 tablets. It includes storage instructions (20° to 25°C) and directs pharmacists to provide the Medication Guide. The label also shows the distributor's address in East Windsor, NJ and indicates the tablets are made in India.*

FDA Label Image

Package Label-principal Display Panel (100 mg Blister Carton (10 x 10 Unit-dose))

This is the packaging label for Lamotrigine Tablets USP 100 mg by Aurobindo Pharma Limited. The label is designed for a package containing 100 tablets (10 x 10 unit-dose). It includes a pharmacist instruction to dispense the accompanying Medication Guide. The label displays the NDC 65862-228-78 and features the Aurobindo logo.*

FDA Label Image

Package Label-principal Display Panel (150 mg (100 Tablet Bottle))

Label for Lamotrigine Tablets USP 150 mg in a 100 tablet quantity, distributed by Aurobindo Pharma USA, Inc. It includes storage instructions for room temperature and advises dispensing the accompanying medication guide. The label features the NDC 65862-229-01 and notes the tablets are made in India by Aurobindo Pharma Limited.*

FDA Label Image

Package Label-principal Display Panel (150 mg Blister Carton (10 x 10 Unit-dose))

The image is a flat, unfolded packaging label for Lamotrigine Tablets USP 150 mg by Aurobindo Pharma Limited. It indicates the product contains 100 tablets in 10 x 10 unit-dose packaging. The label includes the NDC number 65862-229-78 and emphasizes the 150 mg strength in orange. The design features text instructions for pharmacists and storage information, along with the Aurobindo logo.*

FDA Label Image

Chemical Structure (Lamotrigine Str)

Chemical structure of the active ingredient Lamotrigine. The diagram shows molecular components including chlorine atoms and amine groups attached to aromatic rings, illustrating the compound's chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.